Managers

VC-backed Karius secures $25 mln loan from Oxford Finance

Oxford Finance LLC has provided a $25 million senior secured facility to Karius Inc, a life science company focused on infectious disease diagnostics with genomics. The financing will be used to expand the company technology to more hospitals and patients, invest in additional clinical studies and fund additional technology and product innovations. Karius Inc's backers include Data Collective, Lightspeed Venture Partners, Tencent, Khosla Ventures, Innovation Endeavors and Spectrum 28.

ParaGen Technologies rakes in $3 mln

Columbus, Ohio-based ParaGen Technologies, the parent company of four medical device companies, has secured $3 million in funding. Ikove Venture Partners managed and organized the round.

Qualcomm unveils $100 mln AI investment fund

Qualcomm unveiled an AI-focused investment fund, Qualcomm Ventures AI Fund, that will steer up to $100 million to startups working with artificial intelligence. Qualcomm Ventures made its first investment from the fund by participating in a Series A round for AnyVision.

China Renaissance K2 Ventures closes on $67.5 mln for two venture-capital funds

China Renaissance K2 Ventures has closed on $67.5 million of capital for two venture-capital funds, according to filings with the SEC.

Fifth Wall collects $64.25 mln for retail fund

Fifth Wall Ventures has raised $64.25 million for its retail fund, according to an SEC filing. The target is $200 million.

ICO activity tumbles, but VCs step up to blockchain

Prime Movers Lab amasses $15.49 mln for debut fund

Prime Movers Lab has raised $15.49 million for its inaugural fund, according to an SEC filing. Jackson, Wyoming-based Prime Movers Lab invests in physics-powered startups founded by Prime Movers.

Antios scores $25 mln Series A

Antios Therapeutics Inc, a biopharmaceutical company, has secured $25 million in Series A financing. Lumira Ventures and Domain Associates led the round.

INKEF appoints Bulthuis as MD and head of healthcare team

INKEF Capital, a Dutch venture firm, has named Roel Bulthuis as managing director and head of healthcare team. Previously, he worked at M Ventures.

ISIF, WuXi and GMI launch $400 mln program to boost Ireland as genomics research hub

The Ireland Strategic Investment Fund, WuXi NextCODE and Genomics Medicine Ireland have launched a $400 million investment program aimed at making Ireland a hub for genomics research and development of new disease treatments and cures. The other investors in this initiative include ARCH Venture Partners, Polaris Partners, Temasek, Yunfeng Capital and Sequoia Capital.